-
Categories
-
Pharmaceutical Intermediates
-
Active Pharmaceutical Ingredients
-
Food Additives
- Industrial Coatings
- Agrochemicals
- Dyes and Pigments
- Surfactant
- Flavors and Fragrances
- Chemical Reagents
- Catalyst and Auxiliary
- Natural Products
- Inorganic Chemistry
-
Organic Chemistry
-
Biochemical Engineering
- Analytical Chemistry
-
Cosmetic Ingredient
- Water Treatment Chemical
-
Pharmaceutical Intermediates
Promotion
ECHEMI Mall
Wholesale
Weekly Price
Exhibition
News
-
Trade Service
A few days ago, the National Organization for Pharmaceutical Joint Procurement Office released the fifth batch of national drug procurement product catalogs, and determined 62 varieties to participate in this procurement, including anticancer drugs, antibiotics, hypertension-related drugs, ophthalmology-related drugs, and psychotropic drugs, etc.
On the 2nd, the announcement of the National Organization of Drug Joint Procurement Office on the issuance of the "National Drug Centralized Procurement Document (GY-YD2021-2)" was officially published, and 62 drugs were determined to participate in the centralized procurement.
According to the published catalog of procurement products, the fifth batch of national drug collection includes drugs in many fields such as tumor chemotherapy drugs, digestive preparations, antibiotics, inhalation preparations, hypertension drugs, ophthalmology-related drugs, and antiviral drugs.
Specifically include: Azithromycin injection, fluconazole injection, linezolid glucose injection, moxifloxacin eye drops, tinidazole oral regular-release dosage form, cefuroxime injection, ceftriaxone injection, ceftazidime injection, ceftazolin injection Type, levofloxacin injection dosage form, etc.
According to the requirements of the document, the agreed procurement volume for each product and region in the first year shall be determined according to the following rules: if the actual number of selected enterprises in the country is one, it is 50% of the calculation base of the agreed procurement volume for the first year; if the actual number of selected enterprises in the country is two, it is the first year 60% of the agreed purchase volume calculation base; if the actual number of selected companies in the country is 3, it is 70% of the first year agreed purchase volume calculation base; if the national actual number of selected companies is 4 or more, it is the first year agreed purchase volume calculation base 80%.
In addition, in accordance with the criteria for determining the selected companies announced this time, the "unit declared price" drop ≥ 50.
According to the arrangement, the centralized procurement will start receiving application materials from 8 am on June 23, 2021, and the deadline for submission is 10 am on the same day.
A few days ago, the National Organization for Pharmaceutical Joint Procurement Office released the fifth batch of national drug procurement product catalogs, and determined 62 varieties to participate in this procurement, including anticancer drugs, antibiotics, hypertension-related drugs, ophthalmology-related drugs, and psychotropic drugs, etc.
On the 2nd, the announcement of the National Organization of Drug Joint Procurement Office on the issuance of the "National Drug Centralized Procurement Document (GY-YD2021-2)" was officially published, and 62 drugs were determined to participate in the centralized procurement.
According to the published catalog of procurement products, the fifth batch of national drug collection includes drugs in many fields such as tumor chemotherapy drugs, digestive preparations, antibiotics, inhalation preparations, hypertension drugs, ophthalmology-related drugs, and antiviral drugs.
Specifically include: Azithromycin injection, fluconazole injection, linezolid glucose injection, moxifloxacin eye drops, tinidazole oral regular-release dosage form, cefuroxime injection, ceftriaxone injection, ceftazidime injection, ceftazolin injection Type, levofloxacin injection dosage form, etc.
According to the requirements of the document, the agreed procurement volume for each product and region in the first year shall be determined according to the following rules: if the actual number of selected enterprises in the country is one, it is 50% of the calculation base of the agreed procurement volume for the first year; if the actual number of selected enterprises in the country is two, it is the first year 60% of the agreed purchase volume calculation base; if the actual number of selected companies in the country is 3, it is 70% of the first year agreed purchase volume calculation base; if the national actual number of selected companies is 4 or more, it is the first year agreed purchase volume calculation base 80%.
In addition, in accordance with the criteria for determining the selected companies announced this time, the "unit declared price" drop ≥ 50.
According to the arrangement, the centralized procurement will start receiving application materials from 8 am on June 23, 2021, and the deadline for submission is 10 am on the same day.
